The PE Ratio as of September 2024 (TTM) for Longeveron Inc. (LGVN) is -0.22

According to Longeveron Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.22. This represents a change of -80.96% compared to the average of -1.16 of the last 4 quarters.

Longeveron Inc. (LGVN) Historical PE Ratio (quarterly & annually)

How has LGVN PE Ratio performed in the past?

The mean historical PE Ratio of Longeveron Inc. over the last ten years is -48.30. The current -0.22 PE Ratio has changed -54.46% with respect to the historical average. Over the past ten years (40 quarters), LGVN's PE Ratio was at its highest in in the March 2024 quarter at -0.44. The PE Ratio was at its lowest in in the March 2020 quarter at -1393.07.

Longeveron Inc. (LGVN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Longeveron Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Longeveron Inc. (LGVN) Average PE Ratio

How has LGVN PE Ratio performed in the past?

The current PE Ratio of Longeveron Inc. (LGVN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Longeveron Inc. (LGVN) PE Ratio vs. Peers

How is LGVN’s PE Ratio compared to its peers?

Longeveron Inc.’s PE Ratio is greater than Nutriband Inc. (-6.76), greater than Quoin Pharmaceuticals, Ltd. (-0.47), greater than RenovoRx, Inc. (-3.02), greater than Virax Biolabs Group Limited (-1.34), greater than Generation Bio Co. (-0.92), greater than Kronos Bio, Inc. (-0.58), greater than Erasca, Inc. (-3.94), greater than C4 Therapeutics, Inc. (-3.44), greater than Edgewise Therapeutics, Inc. (-14.14), greater than Surrozen, Inc. (-0.55), greater than Bolt Biotherapeutics, Inc. (-0.37), greater than Larimar Therapeutics, Inc. (-8.80), greater than Keros Therapeutics, Inc. (-11.28), greater than Kezar Life Sciences, Inc. (-0.41), less than Blue Water Vaccines, Inc. (-0.17), less than Revelation Biosciences, Inc. (-0.09), less than Hillstream BioPharma, Inc. (-0.00), less than Kiora Pharmaceuticals, Inc. (4.61), greater than ABVC BioPharma, Inc. (-0.66), greater than Indaptus Therapeutics, Inc. (-0.78), greater than Pasithea Therapeutics Corp. (-0.27), less than Better Therapeutics, Inc. (-0.00), greater than Forte Biosciences, Inc. (-0.39),

Build a custom stock screener for Longeveron Inc. (LGVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Longeveron Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Longeveron Inc. (LGVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Longeveron Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.